Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$4.6M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 16 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 58 most recent Form 4 transactions.
| $80.7K |
| -1.9% |
| Open the original filing on SEC.gov |
| Sep 8 | BCAX | Bicara Therapeutics Inc. | SSELL◷ | 14,058 | $22.77 | $320.1K | -7.1% | Open the original filing on SEC.gov |
| Sep 8 | BCAX | Bicara Therapeutics Inc. | MEXER◷ | 17,500 | $3.79 | $66.3K | +9.6% | Open the original filing on SEC.gov |
| Aug 10 | BCAX | Bicara Therapeutics Inc. | MEXER◷◆ | 18,750 | — | — | — | Open the original filing on SEC.gov |
| Aug 10 | BCAX | Bicara Therapeutics Inc. | SSELL◷ | 18,750 | $27.98 | $524.5K | -9.4% | Open the original filing on SEC.gov |
| Aug 10 | BCAX | Bicara Therapeutics Inc. | MEXER◷ | 18,750 | $3.79 | $71.1K | +10.3% | Open the original filing on SEC.gov |
| Jul 9 | BCAX | Bicara Therapeutics Inc. | SSELL◷ | 536 | $29.00 | $15.5K | -0.3% | Open the original filing on SEC.gov |
| Jul 8 | BCAX | Bicara Therapeutics Inc. | MEXER◷◆ | 18,750 | — | — | — | Open the original filing on SEC.gov |
| Jul 8 | BCAX | Bicara Therapeutics Inc. | SSELL◷ | 1,075 | $30.35 | $32.6K | -0.6% | Open the original filing on SEC.gov |
| Jul 8 | BCAX | Bicara Therapeutics Inc. | SSELL◷ | 4,306 | $29.80 | $128.3K | -2.3% | Open the original filing on SEC.gov |
| Jul 8 | BCAX | Bicara Therapeutics Inc. | SSELL◷ | 22,833 | $28.76 | $656.7K | -10.8% | Open the original filing on SEC.gov |
| Jul 8 | BCAX | Bicara Therapeutics Inc. | MEXER◷ | 18,750 | $3.79 | $71.1K | +9.8% | Open the original filing on SEC.gov |
| May 15 | BCAX | Bicara Therapeutics Inc. | MEXER◷◆ | 8,000 | — | — | — | Open the original filing on SEC.gov |
| May 15 | BCAX | Bicara Therapeutics Inc. | SSELL◷ | 4,500 | $20.29 | $91.3K | -2.3% | Open the original filing on SEC.gov |
| May 15 | BCAX | Bicara Therapeutics Inc. | SSELL◷ | 8,000 | $20.29 | $162.3K | -3.9% | Open the original filing on SEC.gov |
| May 15 | BCAX | Bicara Therapeutics Inc. | MEXER◷ | 8,000 | $3.79 | $30.3K | +4.1% | Open the original filing on SEC.gov |
| Apr 15 | BCAX | Bicara Therapeutics Inc. | MEXER◷◆ | 8,000 | — | — | — | Open the original filing on SEC.gov |
| Apr 15 | BCAX | Bicara Therapeutics Inc. | SSELL◷ | 4,500 | $23.01 | $103.5K | -2.2% | Open the original filing on SEC.gov |
| Apr 15 | BCAX | Bicara Therapeutics Inc. | SSELL◷ | 8,000 | $23.01 | $184.1K | -3.8% | Open the original filing on SEC.gov |
| Apr 15 | BCAX | Bicara Therapeutics Inc. | MEXER◷ | 8,000 | $3.79 | $30.3K | +4.0% | Open the original filing on SEC.gov |
| Mar 16 | BCAX | Bicara Therapeutics Inc. | MEXER◷◆ | 8,000 | — | — | — | Open the original filing on SEC.gov |
| Mar 16 | BCAX | Bicara Therapeutics Inc. | SSELL◷ | 4,500 | $19.66 | $88.5K | -2.2% | Open the original filing on SEC.gov |
| Mar 16 | BCAX | Bicara Therapeutics Inc. | SSELL◷ | 8,000 | $19.66 | $157.3K | -3.8% | Open the original filing on SEC.gov |
| Mar 16 | BCAX | Bicara Therapeutics Inc. | MEXER◷ | 8,000 | $3.79 | $30.3K | +3.9% | Open the original filing on SEC.gov |
| Mar 3 | BCAX | Bicara Therapeutics Inc. | MEXER◷◆ | 12,892 | — | — | — | Open the original filing on SEC.gov |
| Mar 3 | BCAX | Bicara Therapeutics Inc. | SSELL◷ | 4,500 | $18.16 | $81.7K | -2.1% | Open the original filing on SEC.gov |
| Mar 3 | BCAX | Bicara Therapeutics Inc. | SSELL◷ | 12,892 | $18.16 | $234.2K | -5.8% | Open the original filing on SEC.gov |
| Mar 3 | BCAX | Bicara Therapeutics Inc. | MEXER◷ | 12,892 | $3.79 | $48.9K | +6.2% | Open the original filing on SEC.gov |
| Feb 25 | BCAX | Bicara Therapeutics Inc. | MEXER◷◆ | 3,108 | — | — | — | Open the original filing on SEC.gov |
| Feb 25 | BCAX | Bicara Therapeutics Inc. | SSELL◷ | 523 | $18.04 | $9.4K | -0.3% | Open the original filing on SEC.gov |
| Feb 25 | BCAX | Bicara Therapeutics Inc. | SSELL◷ | 3,108 | $18.04 | $56.1K | -1.5% | Open the original filing on SEC.gov |
| Feb 25 | BCAX | Bicara Therapeutics Inc. | MEXER◷ | 3,108 | $3.79 | $11.8K | +1.5% | Open the original filing on SEC.gov |
| Feb 2 | BCAX | Bicara Therapeutics Inc. | AGRANT◆ | 300,000 | — | — | — | Open the original filing on SEC.gov |
| Jan 22 | BCAX | Bicara Therapeutics Inc. | SSELL◷ | 3,828 | $18.10 | $69.3K | -1.8% | Open the original filing on SEC.gov |
| Jan 15 | BCAX | Bicara Therapeutics Inc. | SSELL◷ | 149 | $18.02 | $2.7K | <0.1% | Open the original filing on SEC.gov |
| Dec 26, 2025 | BCAX | Bicara Therapeutics Inc. | MEXER◆ | 25,000 | — | — | — | Open the original filing on SEC.gov |
| Dec 26, 2025 | BCAX | Bicara Therapeutics Inc. | MEXER | 25,000 | $4.44 | $110.9K | +13.2% | Open the original filing on SEC.gov |
| Dec 15, 2025 | BCAX | Bicara Therapeutics Inc. | MEXER◷◆ | 8,000 | — | — | — | Open the original filing on SEC.gov |
| Dec 15, 2025 | BCAX | Bicara Therapeutics Inc. | SSELL◷ | 4,500 | $18.68 | $84.1K | -2.3% | Open the original filing on SEC.gov |
| Dec 15, 2025 | BCAX | Bicara Therapeutics Inc. | SSELL◷ | 8,000 | $18.68 | $149.5K | -4.0% | Open the original filing on SEC.gov |
| Dec 15, 2025 | BCAX | Bicara Therapeutics Inc. | MEXER◷ | 8,000 | $3.79 | $30.3K | +4.1% | Open the original filing on SEC.gov |
| Nov 21, 2025 | BCAX | Bicara Therapeutics Inc. | MEXER◷◆ | 8,000 | — | — | — | Open the original filing on SEC.gov |
| Nov 21, 2025 | BCAX | Bicara Therapeutics Inc. | SSELL◷ | 4,500 | $18.05 | $81.2K | -2.3% | Open the original filing on SEC.gov |
| Nov 21, 2025 | BCAX | Bicara Therapeutics Inc. | SSELL◷ | 8,000 | $18.05 | $144.4K | -3.9% | Open the original filing on SEC.gov |
| Nov 21, 2025 | BCAX | Bicara Therapeutics Inc. | MEXER◷ | 8,000 | $3.79 | $30.3K | +4.0% | Open the original filing on SEC.gov |
| Oct 15, 2025 | BCAX | Bicara Therapeutics Inc. | MEXER◷◆ | 8,000 | — | — | — | Open the original filing on SEC.gov |
| Oct 15, 2025 | BCAX | Bicara Therapeutics Inc. | SSELL◷ | 4,500 | $18.16 | $81.7K | -2.2% | Open the original filing on SEC.gov |
| Oct 15, 2025 | BCAX | Bicara Therapeutics Inc. | SSELL◷ | 8,000 | $18.16 | $145.2K | -3.8% | Open the original filing on SEC.gov |
| Oct 15, 2025 | BCAX | Bicara Therapeutics Inc. | MEXER◷ | 8,000 | $3.79 | $30.3K | +4.0% | Open the original filing on SEC.gov |
| Oct 7, 2025 | BCAX | Bicara Therapeutics Inc. | MEXER◷◆ | 8,000 | — | — | — | Open the original filing on SEC.gov |
| Oct 7, 2025 | BCAX | Bicara Therapeutics Inc. | SSELL◷ | 2,900 | $18.06 | $52.4K | -1.4% | Open the original filing on SEC.gov |
| Oct 7, 2025 | BCAX | Bicara Therapeutics Inc. | SSELL◷ | 8,000 | $18.06 | $144.5K | -3.8% | Open the original filing on SEC.gov |
| Oct 7, 2025 | BCAX | Bicara Therapeutics Inc. | MEXER◷ | 8,000 | $3.79 | $30.3K | +3.9% | Open the original filing on SEC.gov |
| Oct 6, 2025 | BCAX | Bicara Therapeutics Inc. | MEXER◷◆ | 24,000 | — | — | — | Open the original filing on SEC.gov |
| Oct 6, 2025 | BCAX | Bicara Therapeutics Inc. | SSELL◷ | 15,600 | $18.06 | $281.7K | -7.0% | Open the original filing on SEC.gov |
| Oct 6, 2025 | BCAX | Bicara Therapeutics Inc. | SSELL◷ | 24,000 | $18.06 | $433.3K | -9.8% | Open the original filing on SEC.gov |
| Oct 6, 2025 | BCAX | Bicara Therapeutics Inc. | MEXER◷ | 24,000 | $3.79 | $91K | +10.8% | Open the original filing on SEC.gov |